HPV vaccine showdown: 2 doses may be as good as 3
NCT ID NCT03943875
First seen Feb 17, 2026 · Last updated May 13, 2026 · Updated 16 times
Summary
This study looked at whether 15-26 year olds need all 3 doses of the HPV vaccine (Gardasil 9) or if 2 doses provide similar protection. Researchers measured antibody levels in 767 participants to compare the immune response. The goal is to see if a simpler schedule works just as well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Medical Branch
Galveston, Texas, 77555, United States
Conditions
Explore the condition pages connected to this study.